insulin NPH
insulin NPH is a pharmaceutical drug with 42 clinical trials. Currently 2 active trials ongoing. Historical success rate of 87.5%.
Success Metrics
Based on 35 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
2
Mid Stage
32
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
35 of 40 finished
12.5%
5 ended early
2
trials recruiting
42
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
RCT Glargine vs NPH for Treatment of DM in Pregnancy
Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes
Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes
The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins
DETERMINE: Detemir vs NPH
Clinical Trials (42)
RCT Glargine vs NPH for Treatment of DM in Pregnancy
Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes
Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes
The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins
DETERMINE: Detemir vs NPH
Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes
Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes
Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes
Safety of Insulin Detemir in Children With Type 1 Diabetes
Efficacy and Safety of Insulin Detemir in Type 1 Diabetes
Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes
Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes
Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes
Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®
Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes
Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes
Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 42